Viewing Study NCT05483868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2026-03-30 @ 6:13 PM
Study NCT ID: NCT05483868
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2022-07-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer
Sponsor: Aura Biosciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-muscle-invasive Bladder Cancer View
None Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG View
None NMIBC View
None Non-Muscle Invasive Bladder Carcinoma View
None Non-Muscle Invasive Bladder Neoplasms View
None Non-Muscle Invasive Bladder Urothelial Carcinoma View
None Urothelial Carcinoma Bladder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NMIBC View
None TURBT View
None Intramural View
None AU-011 View
None Belzupacap Sarotalocan View
None Intratumoral View
None urothelial View
None bladder cancer View
None bel-sar View